Zhongyuan Union Stem Cell Bioengineering Co., Ltd. announced that the board of directors at its meeting held on March 18, 2013, approved the appointment of He Wei as CFO.
Vcanbio Cell & Gene Engineering Corp., Ltd
Equities
600645
CNE000000545
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
17.08 CNY | +0.89% | -0.70% | -15.74% |
1st Jan change | Capi. | |
---|---|---|
-15.74% | 1.08B | |
-2.58% | 8.11B | |
+7.73% | 5.67B | |
+29.76% | 5.62B | |
-15.77% | 3.89B | |
+12.42% | 2.68B | |
-61.85% | 2.58B | |
-5.50% | 2.26B | |
+23.09% | 2.03B | |
-9.25% | 1.82B |
- Stock Market
- Equities
- 600645 Stock
- News Vcanbio Cell & Gene Engineering Corp., Ltd
- Zhongyuan Union Stem Cell Bioengineering Co., Ltd. Appoints He Wei as CFO